217 related articles for article (PubMed ID: 33824863)
1. Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma.
Weng J; Zhou C; Zhou Q; Chen W; Yin Y; Atyah M; Dong Q; Shi Y; Ren N
J Hepatocell Carcinoma; 2021; 8():193-209. PubMed ID: 33824863
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
Wang Y; Song F; Zhang X; Yang C
Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
[TBL] [Abstract][Full Text] [Related]
3. Glycolysis-Related Gene Signature Can Predict Survival and Immune Status of Hepatocellular Carcinoma.
Xu Q; Miao D; Song X; Chen Z; Zeng L; Zhao L; Xu J; Lin Z; Yu F
Ann Surg Oncol; 2022 Jun; 29(6):3963-3976. PubMed ID: 35266081
[TBL] [Abstract][Full Text] [Related]
4. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Liu GM; Zeng HD; Zhang CY; Xu JW
Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
[TBL] [Abstract][Full Text] [Related]
5. A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
J Hepatocell Carcinoma; 2021; 8():119-132. PubMed ID: 33758763
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
Front Oncol; 2021; 11():629327. PubMed ID: 33718205
[TBL] [Abstract][Full Text] [Related]
7. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
Lin Z; Xu Q; Miao D; Yu F
Front Oncol; 2021; 11():644416. PubMed ID: 33828988
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an eight-gene signature based predictive model to evaluate the prognosis of hepatocellular carcinoma patients: a bioinformatic study.
Zhang J; Fu X; Zhang N; Wang W; Liu H; Jia Y; Nie Y
Ann Transl Med; 2022 May; 10(9):524. PubMed ID: 35928748
[TBL] [Abstract][Full Text] [Related]
9. Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma.
Li Q; Jin L; Jin M
Front Genet; 2021; 12():613890. PubMed ID: 34194464
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma.
Xia X; Tang P; Liu H; Li Y
J Clin Transl Hepatol; 2021 Dec; 9(6):798-808. PubMed ID: 34966643
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis.
Zhu W; Ru L; Ma Z
Front Oncol; 2021; 11():626654. PubMed ID: 33777771
[TBL] [Abstract][Full Text] [Related]
13. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene-related signature associated with prognosis and therapy response.
Chen L; Zhang D; Zheng S; Li X; Gao P
Front Genet; 2022; 13():959834. PubMed ID: 36110210
[No Abstract] [Full Text] [Related]
14. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
15. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Bai Y; Lin H; Chen J; Wu Y; Yu S
Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
[No Abstract] [Full Text] [Related]
16. An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma.
Yao N; Jiang W; Wang Y; Song Q; Cao X; Zheng W; Zhang J
Eur J Med Res; 2023 Mar; 28(1):123. PubMed ID: 36918943
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
18. Prognostic and predictive role of a metabolic rate-limiting enzyme signature in hepatocellular carcinoma.
Wang Z; Fu Y; Xia A; Chen C; Qu J; Xu G; Zou X; Wang Q; Wang S
Cell Prolif; 2021 Oct; 54(10):e13117. PubMed ID: 34423480
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
20. Exploring potential targets of Actinidia chinensis Planch root against hepatocellular carcinoma based on network pharmacology and molecular docking and development and verification of immune-associated prognosis features for hepatocellular carcinoma.
Qu M; Han T; Chen X; Sun Q; Li Q; Zhao M
J Gastrointest Oncol; 2022 Jun; 13(3):1289-1307. PubMed ID: 35837167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
